CoChat

Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro

Open access
Benninghoff, Abby D., Bisson, William H., Koch, Daniel C., Ehresman, David J., Kolluri, Siva K., Williams, David E. · 2011 · Toxicological Sciences
Cited by 248

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The objectives of this study were to determine the structural characteristics of perfluoroalkyl acids (PFAAs) that confer estrogen-like activity in vivo using juvenile rainbow trout (Oncorhynchus mykiss) as an animal model and to determine whether these chemicals interact directly with the estrogen receptor (ER) using in vitro and in silico species comparison approaches. Perfluorooctanoic (PFOA), perfluorononanoic (PFNA), perfluorodecanoic (PFDA), and perfluoroundecanoic (PFUnDA) acids were all potent inducers of the estrogen-responsive biomarker protein vitellogenin (Vtg) in vivo, although at fairly high dietary exposures. A structure-activity relationship for PFAAs was observed, where eight to ten fluorinated carbons and a carboxylic acid end group were optimal for maximal Vtg induction. These in vivo findings were corroborated by in vitro mechanistic assays for trout and human ER. All PFAAs tested weakly bound to trout liver ER with half maximal inhibitory concentration (IC(50)) values of 15.2-289 μM. Additionally, PFOA, PFNA, PFDA, PFUnDA, and perlfuorooctane sulfonate (PFOS) significantly enhanced human ERα-dependent transcriptional activation at concentrations ranging from 10-1000 nM. Finally, we employed an in silico computational model based upon the crystal structure for the human ERα ligand-binding domain complexed with E2 to structurally investigate binding of these putative ligands to human, mouse, and trout ERα. PFOA, PFNA, PFDA, and PFOS all efficiently docked with ERα from different species and formed a hydrogen bond at residue Arg394/398/407 (human/mouse/trout) in a manner similar to the environmental estrogens bisphenol A and nonylphenol. Overall, these data support the contention that several PFAAs are weak environmental xenoestrogens of potential concern.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfq379

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 47

  1. 1994, ICM—a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation, J. Comput. Chem., 15, 488, 10.1002/jcc.540150503 · DOI · Paper page
  2. 1991, The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator, Toxicol. Appl. Pharmacol., 111, 530, 10.1016/0041-008X(91)90257-F · DOI
  3. 2008, Identification of a transcriptional fingerprint of estrogen exposure in rainbow trout liver, Toxicol. Sci., 101, 65, 10.1093/toxsci/kfm238 · doi:10.1093/toxsci/kfm238
  4. 2005, Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis, Toxicology, 206, 309, 10.1016/j.tox.2004.07.015 · DOI
  5. 1995, Homology modeling by the ICM method, Proteins, 23, 403, 10.1002/prot.340230314 · DOI · Paper page
  6. 2000, Estrogens as endogenous genotoxic agents—DNA adducts and mutations, J. Natl. Cancer Inst. Monogr., 27, 75
  7. 2002, Sex hormones and liver cancer, Mol. Cell. Endocrinol., 193, 59, 10.1016/S0303-7207(02)00096-5 · DOI · Paper page
  8. 2008, Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies, Adv. Exp. Med. Biol., 630, 148, 10.1007/978-0-387-78818-0_10 · DOI
  9. 2006, Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources, J. Occup. Environ. Med., 48, 759, 10.1097/01.jom.0000232486.07658.74 · DOI · Paper page
  10. 1998, Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage, Mol. Endocrinol., 12, 1939
  11. 2009, Perfluorinated compounds—exposure assessment for the general population in Western countries, Int. J. Hyg. Environ. Health, 212, 239, 10.1016/j.ijheh.2008.04.007 · DOI · Paper page
  12. 2009, A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants, Environ. Health Perspect., 117, 1664, 10.1289/ehp.0900758 · DOI · Paper page
  13. 1988, A Proposed Species Difference in the Renal Excretion of Perfluorooctanoic Acid in the Beagle Dog and Rat, 409
  14. 2003, Estrogen, progesterone and epithelial ovarian cancer, Reprod. Biol. Endocrinol., 1, 73, 10.1186/1477-7827-1-73 · DOI · Paper page
  15. 1999, Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences, J. Mol. Endocrinol., 22, 1, 10.1677/jme.0.0220001 · DOI · Paper page
  16. 2006, Biological monitoring of polyfluoroalkyl substances: a review, Environ. Sci. Technol., 40, 3463, 10.1021/es052580b · DOI · Paper page
  17. 2007, Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro, Biol. Pharm. Bull., 30, 1358, 10.1248/bpb.30.1358 · DOI
  18. 2008, Fluorotelomer alcohols induce hepatic vitellogenin through activation of the estrogen receptor in male medaka (Oryzias latipes), Chemosphere, 71, 1853, 10.1016/j.chemosphere.2008.01.065 · DOI
  19. 2007, Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway, J. Occup. Health, 49, 172, 10.1539/joh.49.172 · DOI · Paper page
  20. 2002, Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas, Environ. Sci. Technol., 36, 3210, 10.1021/es020519q · DOI · Paper page
  21. 2003, Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells, Mol. Cell. Biol., 23, 8651, 10.1128/MCB.23.23.8651-8667.2003 · DOI · Paper page
  22. 2003, Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals, J. Toxicol. Sci., 28, 49, 10.2131/jts.28.49 · DOI · Paper page
  23. 2004, Rodent carcinogenicity of peroxisome proliferators and issues on human relevance, J. Environ. Sci. Health C, 22, 37, 10.1081/GNC-120038005 · DOI
  24. 2010, Endocrine disruption and reproductive impairment in zebrafish by exposure to 8:2 fluorotelomer alcohol, Aquat. Toxicol., 96, 70, 10.1016/j.aquatox.2009.09.012 · DOI
  25. 2007, Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes, Aquat. Toxicol., 85, 267, 10.1016/j.aquatox.2007.09.009 · DOI · Paper page
  26. 2009, Waterborne exposure to fluorotelomer alcohol 6:2 FTOH alters plasma sex hormone and gene transcription in the hypothalamic-pituitary-gonadal (HPG) axis of zebrafish, Aquat. Toxicol., 93, 131, 10.1016/j.aquatox.2009.04.005 · DOI
  27. 2006, Homology model of the rainbow trout estrogen receptor (rtERalpha) and docking of endocrine disrupting chemicals (EDCs), SAR QSAR Environ. Res., 17, 93, 10.1080/10659360600562137 · doi:10.1080/10659360600562137
  28. 2005, Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes, Chem. Biol. Interact., 155, 165, 10.1016/j.cbi.2005.06.007 · DOI · Paper page
  29. 2003, Dietary accumulation of perfluorinated acids in juvenile rainbow trout (Oncorhynchus mykiss), Environ. Toxicol. Chem., 22, 189, 10.1002/etc.5620220125 · DOI · Paper page
  30. 2000, Differential estrogen receptor binding of estrogenic substances: a species comparison, J. Steroid Biochem. Mol. Biol., 74, 223, 10.1016/S0960-0760(00)00126-6 · DOI · Paper page
  31. 1985, Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate, Toxicol. Appl. Pharmacol., 80, 23, 10.1016/0041-008X(85)90097-3 · DOI
  32. 2007, In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement, Toxicol. Sci., 100, 333, 10.1093/toxsci/kfm230 · DOI · Paper page
  33. 2007, The complete nuclear estrogen receptor family in the rainbow trout: discovery of the novel ERalpha2 and both ERbeta isoforms, Gene, 392, 164, 10.1016/j.gene.2006.12.030 · DOI · Paper page
  34. 1989, Promotion of aflatoxin B1 hepatocarcinogenesis in rainbow trout by 17β-estradiol, Aquat. Toxicol., 15, 289, 10.1016/0166-445X(89)90042-8 · doi:10.1016/0166-445x(89)90042-8
  35. 2005, Estrogenic effects of environmental chemicals: an interspecies comparison, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 141, 267, 10.1016/j.cca.2005.07.002 · doi:10.1016/j.cca.2005.07.002
  36. 1995, Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout, Carcinogenesis, 16, 2893, 10.1093/carcin/16.12.2893 · doi:10.1093/carcin/16.12.2893
  37. 1998, Peroxisome proliferator activated receptor-alpha expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14 · DOI · Paper page
  38. 2000, Estrogens in the causation of breast, endometrial and ovarian cancers—evidence and hypotheses from epidemiological findings, J. Steroid Biochem. Mol. Biol., 74, 357, 10.1016/S0960-0760(00)00113-8 · DOI · Paper page
  39. 2000, Determining relative estrogenicity by quantifying vitellogenin induction in rainbow trout liver slices, Toxicol. Appl. Pharmacol., 164, 330, 10.1006/taap.2000.8912 · doi:10.1006/taap.2000.8912
  40. 2005, In-silico screening using flexible ligand binding pockets: a molecular dynamics-based approach, J. Comput. Aided Mol. Des., 19, 213, 10.1007/s10822-005-4788-9 · DOI
  41. 2008, Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout, Environ. Health Perspect., 116, 1047, 10.1289/ehp.11190 · DOI
  42. 1997, Flexible protein-ligand docking by global energy optimization in internal coordinates, Proteins, 215
  43. 2001, Protein-Ligand Docking as an Energy Optimization Problem, 603
  44. 2008, Role of estrogen in liver cancer, Womens Health (Lond. Engl.), 4, 41, 10.2217/17455057.4.1.41 · DOI
  45. 2007, Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus), Environ. Toxicol. Chem., 26, 2440, 10.1897/07-008R1.1 · DOI
  46. 1991, Sex hormones and tumor promotion in liver, Proc. Soc. Exp. Biol. Med., 198, 667, 10.3181/00379727-198-43305 · doi:10.3181/00379727-198-43305
  47. 2010, Gender disparity of hepatocellular carcinoma: the roles of sex hormones, Oncology, 78, 172, 10.1159/000315247 · DOI · Paper page

Cited by

See all 248

Metadata

Authors
Benninghoff, A. D., Bisson, W. H., Koch, D. C., Ehresman, D. J., Kolluri, S. K., & Williams, D. E.
Venue
Toxicological Sciences
Published
2010-12-16
Volume
120
Issue
1
Pages
42-58
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2064507515
Cited by
248
References
8
FWCI
5.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro. https://app.cochat.ai/papers/10.1093/toxsci/kfq379
The paper
Benninghoff, A. D., Bisson, W. H., Koch, D. C., Ehresman, D. J., Kolluri, S. K., & Williams, D. E. (2011). Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfq379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.